MX356478B - 6-((s)-1-{1-[5-(2-hidroxi-etoxi)-piridin-2-il]1h-pirazol-3-il}-et il)-3h-1,3-benzotiazol-2-ona como un antagonista del receptor ampa dependiente de tarp-gamma 8. - Google Patents

6-((s)-1-{1-[5-(2-hidroxi-etoxi)-piridin-2-il]1h-pirazol-3-il}-et il)-3h-1,3-benzotiazol-2-ona como un antagonista del receptor ampa dependiente de tarp-gamma 8.

Info

Publication number
MX356478B
MX356478B MX2015006697A MX2015006697A MX356478B MX 356478 B MX356478 B MX 356478B MX 2015006697 A MX2015006697 A MX 2015006697A MX 2015006697 A MX2015006697 A MX 2015006697A MX 356478 B MX356478 B MX 356478B
Authority
MX
Mexico
Prior art keywords
tarp
receptor antagonist
pyrazo
benzothiazol
pyridin
Prior art date
Application number
MX2015006697A
Other languages
English (en)
Other versions
MX2015006697A (es
Inventor
Kevin Reel Jon
Jaye Porter Warren
Michael Witkin Jeffrey
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MX2015006697A publication Critical patent/MX2015006697A/es
Publication of MX356478B publication Critical patent/MX356478B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Se describen un antagonista del receptor AMPA dependiente de TARP ?8 de la fórmula: (I) sus sales farmacéuticamente aceptables, usos, y métodos para su preparación. (ver Fórmula).
MX2015006697A 2012-11-27 2013-11-20 6-((s)-1-{1-[5-(2-hidroxi-etoxi)-piridin-2-il]1h-pirazol-3-il}-et il)-3h-1,3-benzotiazol-2-ona como un antagonista del receptor ampa dependiente de tarp-gamma 8. MX356478B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261730273P 2012-11-27 2012-11-27
PCT/US2013/070885 WO2014085153A1 (en) 2012-11-27 2013-11-20 6-((s)-1-{1-[5-(2-hydroxy-ethoxy)-pyridin-2-yl]-1h-pyrazol-3-yl}- ethyl)-3h-1,3-benzothiazol-2-one as a tarp-gamma 8 dependent ampa receptor antagonist

Publications (2)

Publication Number Publication Date
MX2015006697A MX2015006697A (es) 2015-08-05
MX356478B true MX356478B (es) 2018-05-30

Family

ID=49753484

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015006697A MX356478B (es) 2012-11-27 2013-11-20 6-((s)-1-{1-[5-(2-hidroxi-etoxi)-piridin-2-il]1h-pirazol-3-il}-et il)-3h-1,3-benzotiazol-2-ona como un antagonista del receptor ampa dependiente de tarp-gamma 8.

Country Status (35)

Country Link
US (1) US8765960B2 (es)
EP (1) EP2925754B1 (es)
JP (1) JP6246227B2 (es)
KR (1) KR101693133B1 (es)
CN (1) CN104797578B (es)
AP (1) AP2015008489A0 (es)
AR (1) AR093527A1 (es)
AU (1) AU2013352594B2 (es)
BR (1) BR112015011200A2 (es)
CA (1) CA2889243C (es)
CL (1) CL2015001419A1 (es)
CR (1) CR20150267A (es)
CY (1) CY1118657T1 (es)
DK (1) DK2925754T3 (es)
DO (1) DOP2015000113A (es)
EA (1) EA026686B1 (es)
ES (1) ES2618260T3 (es)
HR (1) HRP20170274T1 (es)
HU (1) HUE033447T2 (es)
IL (1) IL238831B (es)
JO (1) JO3225B1 (es)
MA (1) MA38126B1 (es)
MX (1) MX356478B (es)
MY (1) MY177721A (es)
PE (1) PE20151728A1 (es)
PH (1) PH12015501154B1 (es)
PL (1) PL2925754T3 (es)
PT (1) PT2925754T (es)
SG (1) SG11201504164VA (es)
SI (1) SI2925754T1 (es)
TN (1) TN2015000200A1 (es)
TW (2) TW201825484A (es)
UA (1) UA114345C2 (es)
WO (1) WO2014085153A1 (es)
ZA (1) ZA201503733B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201609719A (zh) * 2014-05-28 2016-03-16 美國禮來大藥廠 作為ＴＡＲＰ－γ８依賴性ＡＭＰＡ受體拮抗劑之６－經取代－３Ｈ－１，３－苯并噻唑－２－酮化合物
CN107750250B (zh) 2015-04-29 2021-09-07 詹森药业有限公司 吲哚酮化合物及其作为ampa受体调节剂的用途
KR20170140382A (ko) 2015-04-29 2017-12-20 얀센 파마슈티카 엔.브이. 아자벤즈이미다졸 및 ampa 수용체 조절제로서의 이의 용도
BR112017023038A2 (pt) 2015-04-29 2018-07-03 Janssen Pharmaceutica Nv imidazopirazinas e pirazolopirimidinas e seu uso como moduladores do receptor ampa
CA2984290C (en) * 2015-04-29 2022-03-01 Janssen Pharmaceutica Nv Benzimidazolone and benzothiazolone compounds and their use as ampa receptor modulators
EP3532477B1 (en) * 2016-10-26 2020-08-26 Janssen Pharmaceutica NV Fused bicylic pyridine compounds and their use as ampa receptor modulators
RU2650523C1 (ru) * 2017-07-24 2018-04-16 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Производное пиридоксина для лечения эпилепсии
RU2703286C1 (ru) * 2019-06-18 2019-10-16 федеральное государственное автономное образовательное учреждение высшего образования "Казанский (Приволжский) федеральный университет" (ФГАОУ ВО КФУ) Соли (5-гидрокси-3,4-бис(гидроксиметил)-6-метилпиридин-2-ил)метансульфокислоты и способ их получения

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY132385A (en) * 1995-08-31 2007-10-31 Novartis Ag 2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
JP2000281676A (ja) * 1999-01-25 2000-10-10 Yamanouchi Pharmaceut Co Ltd Ａｍｐａ拮抗化合物の新規製造法
MXPA02012314A (es) 2000-06-12 2004-09-06 Eisai Co Ltd Compuestos de 1,2-dihidropiridina, metodo de fabricacion y utilizacion de los mismos.
US8995993B2 (en) * 2000-10-11 2015-03-31 Gogo Llc System for managing mobile internet protocol addresses in an airborne wireless cellular network
CN101072775A (zh) * 2004-12-17 2007-11-14 伊莱利利公司 新的mch受体拮抗剂
WO2007076161A2 (en) 2005-12-27 2007-07-05 Myriad Genetics, Inc Compounds with therapeutic activity
TW200817385A (en) * 2006-07-04 2008-04-16 Organon Nv Heterocyclic derivatives
EP2356099A1 (en) * 2008-10-08 2011-08-17 Pfizer Inc. Tetrahydrofuranyl sulfonamides for use as ampa modulators in the treatment of cns disorders
EA020460B1 (ru) * 2009-01-12 2014-11-28 Пфайзер Лимитед Производные сульфонамида
CN102985420B (zh) * 2010-06-01 2017-07-04 安吉翁生物医药有限公司 细胞色素p450抑制剂及其用途
US9527807B2 (en) * 2011-04-05 2016-12-27 Takeda Pharmaceutical Company Limited Sulfonamide derivative and use thereof
TW201609719A (zh) * 2014-05-28 2016-03-16 美國禮來大藥廠 作為ＴＡＲＰ－γ８依賴性ＡＭＰＡ受體拮抗劑之６－經取代－３Ｈ－１，３－苯并噻唑－２－酮化合物

Also Published As

Publication number Publication date
IL238831A0 (en) 2015-06-30
HRP20170274T1 (hr) 2017-04-07
AP2015008489A0 (en) 2015-05-31
WO2014085153A8 (en) 2014-07-31
MA38126A1 (fr) 2017-03-31
EP2925754B1 (en) 2016-12-28
AU2013352594B2 (en) 2016-02-18
CL2015001419A1 (es) 2015-10-02
EP2925754A1 (en) 2015-10-07
WO2014085153A1 (en) 2014-06-05
TW201434834A (zh) 2014-09-16
DOP2015000113A (es) 2015-06-15
EA026686B1 (ru) 2017-05-31
PL2925754T3 (pl) 2017-07-31
PE20151728A1 (es) 2015-12-02
CN104797578A (zh) 2015-07-22
TW201825484A (zh) 2018-07-16
MA38126B1 (fr) 2017-11-30
KR101693133B1 (ko) 2017-01-04
CA2889243A1 (en) 2014-06-05
US8765960B2 (en) 2014-07-01
US20140148441A1 (en) 2014-05-29
CN104797578B (zh) 2016-11-23
AU2013352594A1 (en) 2015-06-04
DK2925754T3 (en) 2017-02-20
IL238831B (en) 2018-08-30
MY177721A (en) 2020-09-23
JP2016501219A (ja) 2016-01-18
BR112015011200A2 (pt) 2017-07-11
KR20150070401A (ko) 2015-06-24
CA2889243C (en) 2017-06-13
SI2925754T1 (sl) 2017-02-28
MX2015006697A (es) 2015-08-05
AR093527A1 (es) 2015-06-10
CY1118657T1 (el) 2017-07-12
PH12015501154B1 (en) 2018-05-30
EA201590823A1 (ru) 2015-08-31
CR20150267A (es) 2015-09-16
HUE033447T2 (en) 2017-11-28
JO3225B1 (ar) 2018-03-08
PH12015501154A1 (en) 2015-08-10
ES2618260T3 (es) 2017-06-21
PT2925754T (pt) 2017-02-27
SG11201504164VA (en) 2015-07-30
JP6246227B2 (ja) 2017-12-13
HK1209116A1 (en) 2016-03-24
TN2015000200A1 (en) 2016-10-03
TWI618705B (zh) 2018-03-21
UA114345C2 (uk) 2017-05-25
ZA201503733B (en) 2017-09-27

Similar Documents

Publication Publication Date Title
MX356478B (es) 6-((s)-1-{1-[5-(2-hidroxi-etoxi)-piridin-2-il]1h-pirazol-3-il}-et il)-3h-1,3-benzotiazol-2-ona como un antagonista del receptor ampa dependiente de tarp-gamma 8.
PH12019502072A1 (en) Sustained release dosage forms for a jak1 inhibitor
WO2012077136A3 (en) Process for the preparation of benzimidazole derivatives and its salts
PH12014502169A1 (en) N-cyclylamides as nematicides
PH12013500870A1 (en) Heterocyclic compounds and uses thereof
MY167575A (en) Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
MX358172B (es) Derivados de pirazol aminopirimidina como moduladores de la proteina cinasa 2 de repeticion rica en leucina (lrrk2) para usarse en el tratamiento de la enfermedad de parkinson.
PH12015501339A1 (en) Indole carboxamide derivatives as p2x7 receptor antagonists
MX2012002387A (es) Aminas de triazol fusionadas como moduladores p2x7.
GB201101517D0 (en) Receptor antagonists
MX339460B (es) Derivados de benzazol como ligandos del receptor h4 de histamina.
MY178583A (en) Hydantoin derivative
MX345142B (es) Derivados de aminoalquilpirimidina como antagonistas del receptor h4 de histamina.
PH12012502300A1 (en) Nicotinic receptor non-competitive antagonists
WO2009081246A3 (en) Bicyclic diamines as nicotinic receptor agonists
TN2011000588A1 (en) Novel pharmaceutically acceptable salts of 4-(1h-imidazol-4-ylmethyl) pyridine and their therapeutical uses
HK1192234A1 (zh) 6-(哌啶-4-基氧基)-2h-异喹啉-1-酮盐酸盐的多晶型物

Legal Events

Date Code Title Description
FG Grant or registration